Results 81 to 90 of about 281,748 (215)

Patient Characteristics, Healthcare Contacts and Drug Use in Polycythaemia Vera in Denmark

open access: yesEuropean Journal of Haematology, Volume 115, Issue 5, Page 474-483, November 2025.
ABSTRACT Objective Patients with polycythaemia vera (PV) may experience symptoms and cardiovascular complications before receiving a diagnosis. Understanding the associated patterns of healthcare and drug utilisation may help detect patients who need diagnostic workup.
Karoline Mathilde Lundgaard   +4 more
wiley   +1 more source

Polycythemia Vera: New Diagnostic Concept and Its Types

open access: yesКлиническая онкогематология, 2016
Polycythemia vera (PV) is a clonal Ph-negative myeloproliferative disorder characterized by excessive myeloid proliferation of three hematopoietic cell lineages leading to ineffective myelopoiesis.
AM Kovrigina, VV Baikov
doaj   +1 more source

How I Treat Polycythemia Vera.

open access: yesBlood, 2019
Since its discovery 125 years ago, polycythemia vera (PV) has been a challenge to the clinicians responsible for its diagnosis and management, and the scientists attempting to define its molecular basis.
J. Spivak
semanticscholar   +1 more source

Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera

open access: yesHaematologica, 2017
Up to 20% of patients with polycythemia vera have karyotypic abnormalities at the time of the initial diagnosis. However, the cytogenetic abnormalities in polycythemia vera have not been well characterized and their prognostic impact is largely unknown ...
Guilin Tang   +13 more
doaj   +1 more source

Polycythemia vera treatment algorithm 2018

open access: yesBlood Cancer Journal, 2018
Recently reported mature survival data have confirmed the favorable prognosis in polycythemia vera (PV), with an estimated median survival of 24 years, in patients younger than age 60 years old.
A. Tefferi, A. Vannucchi, T. Barbui
semanticscholar   +1 more source

What's Your Diagnosis? A Case of Extreme Thrombocytosis in a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Stephanie F. Anderson   +5 more
wiley   +1 more source

CALR Type 1‐Like Mutations Increase Endoplasmic Reticulum Free Ca2+ and Induce ERK1/2 Activation Independent of Thrombopoietin Receptor Activation

open access: yesCell Biology International, Volume 49, Issue 10, Page 1262-1273, October 2025.
ABSTRACT Calreticulin is a multifunctional protein found in the endoplasmic reticulum lumen that is important for calcium homeostasis and glycoprotein folding. Mutations in exon 9 of the CALR gene are the second most common genetic cause of myeloproliferative neoplasms.
Mifra Faiz   +2 more
wiley   +1 more source

Supplementary Table from RETRACTED: <i>In Vivo</i> Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target [PDF]

open access: gold, 2023
Shohei Murakami   +16 more
openalex   +1 more source

Hyperkalemia in Clinical Practice, an Important Reminder of Testing Modality

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT We describe a patient with hyperkalemia and ECG changes with persistent mild hyperkalemia without ECG changes following treatment. Their hyperkalemia was confounded by the presence of true hyperkalemia due to an acute kidney injury and pseudohyperkalemia due to significant thrombocytosis.
Andrew G. Turner, Deepak L. Vardesh
wiley   +1 more source

Home - About - Disclaimer - Privacy